Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sodium Chloride × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Breast Neoplasms 32 Pain, Postoperative 4 Chronic Pain 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Breast Diseases 2 Brain Neoplasms 2 Agnosia 2 Vulvodynia 1 Uterine Cervical Neoplasms 1 Skin Diseases 1 Seroma 1 Recurrence 1 Radiation Injuries 1 Postoperative Hemorrhage 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell, Marginal Zone 1 Hot Flashes 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gangliosidosis, GM1 1 Gangliosidoses 1

Interventions

Cyclophosphamide 6 Radiotherapy 5 olaparib 3 Paclitaxel 3 Letrozole 3 Itraconazole 3 Carboplatin 3 Blood Specimen Collection 3 palbociclib 2 fludarabine phosphate 2 exemestane 2 eribulin 2 avelumab 2 abemaciclib 2 Therapeutics 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Mastectomy 2 Gemcitabine 2 Fulvestrant 2 Flow Cytometry 2 Exercise 2 Etoposide 2 Cetuximab 2 Carmustine 2 Bevacizumab 2 Antilymphocyte Serum 2 Anastrozole 2 Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00925548 2014-07-24

STRIDE

EMD Serono

Phase 3 Terminated

16 enrolled 6 charts

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡